The Journal of antimicrobial chemotherapyHumansHIV InfectionsMaleFemaleEmtricitabine
From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV.
José L Casado, José L Blanco, Isabel Izuzquiza, Ana Moreno, Pilar Vizcarra, Alejandro Vallejo
Published: 202510.1093/jac/dkaf357
Abstract
BACKGROUND: We evaluated the maintenance of virological suppression in people living with multidrug resistance (MDR) HIV (PLWH), who simplified to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF). METHODS: We conducted a prospective, obs…
Preview only. Read the full abstract at the source